Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience
-
Published:2024-07
Issue:1
Volume:64
Page:107190
-
ISSN:0924-8579
-
Container-title:International Journal of Antimicrobial Agents
-
language:en
-
Short-container-title:International Journal of Antimicrobial Agents
Author:
Russo AlessandroORCID,
Gullì Sara PalmaORCID,
D'Avino Alessandro,
Borrazzo Cristian,
Carannante Novella,
Dezza Francesco CogliatiORCID,
Covino Sara,
Polistina Giorgio,
Fiorentino Giuseppe,
Trecarichi Enrico Maria,
Mastroianni Claudio Maria,
Torti Carlo,
Oliva AlessandraORCID
Reference24 articles.
1. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit;Russo;Infection,2022
2. Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study;Russo;J Infect,2019
3. Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Version 2.0;Tamma,2022
4. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine);Paul;Clin Microbiol Infect,2022
5. Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献